Frontlight ResearchEarly access
CompletedNo phase
Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain
Key facts
- Who runs it
- Paradigm Biopharmaceuticals Ltd.
- Where
- Chicago, United StatesSee the siteAlso in 1 other country, 1 site
- Trial code
- Status
- Completed
- People taking part
- 133 people enrolled
- Started
- 24 Jun 2023
- Ended
- 24 Dec 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- Pentosan Polysulphate Sodium
- Placebo (Sodium Chloride Injection, 0.9%)
- Record updated
- 22 July 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (3)Hide the full registry criteria
Who can take part
- Participants who completed Day 168 of Study PARA_OA_002 (ie, did not discontinue/withdrew prematurely from the parent study)
- Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol
Who cannot take part
- An employee of the Sponsor, clinical research organisations or research site personnel directly affiliated with this study or their immediate family members defined as a spouse, parent, sibling, or child, whether biological or legally adopted
Where in United States
Also in 1 other country, 1 site
- Northwestern University Feinberg School of MedicineChicago, United States
About the trial
What the trial wants to find out
The purpose of this study is to measure the duration of treatment effect with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with placebo in adult participants with knee osteoarthritis (OA) pain. The study duration will be up to 34 weeks.
Read full original descriptionShow less
Participants who completed pDay 162 of Study PARA_OA_002 (i.e. did not discontinue/withdraw prematurely from the parent study) will be invited to participate.
The 2 groups in the trial
- Pentosan Polysulfate Sodium
Pentosan Polysulfate Sodium (PPS) at Dose and frequency selected in Stage 1 of Parent Study for 6 weeks
Treatment: Pentosan Polysulphate Sodium
- Placebo
Placebo for 6 weeks
Treatment: Placebo (Sodium Chloride Injection, 0.9%)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Observational Follow-up Study to Investigate the Duration of Treatment Effect With Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain
- Record updated
- 22 July 2025